This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: Claude Gueniau: Innovator in Pharmaceutical Chemistry
Introduction
Claude Gueniau is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of novel compounds.
Latest Patents
Gueniau holds a patent for "Tetrahydrobenz(c,d)indoles and pharmaceutical use." This patent describes novel tetrahydrobenz[c,d]indoles of a specific formula, wherein R is selected from hydrogen, alkyl groups of 1 to 6 carbon atoms, and cycloalkyl groups of 3 to 6 carbon atoms. Additionally, R1 can be hydrogen, chlorine, or bromine, along with their non-toxic, pharmaceutically acceptable acid addition salts. These compounds exhibit antianoxic, hypotensive, antihypertensive, and dopaminergic agonist activity.
Career Highlights
Gueniau's career is marked by his dedication to advancing pharmaceutical science. He has worked with Roussel Uclaf, a company known for its focus on innovative healthcare solutions. His work has contributed to the development of new therapeutic agents that can improve patient outcomes.
Collaborations
Throughout his career, Gueniau has collaborated with esteemed colleagues, including Lucien Nedelec and Claude Rettien. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Claude Gueniau's contributions to pharmaceutical chemistry through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the field and improve healthcare solutions.